The acceptability and effectiveness of a questionnaire for the identification of risk factors for HIV and hepatitis B and C: An observational study in general practice.

Am��lie A��m-Eus��bi, Emmanuel Prothon, Catherine Majerholc, Diana Barger, Yazdan Yazdanpanah, Jean-Pierre Aubert
Author Information
  1. Am��lie A��m-Eus��bi: a D��partement de m��decine g��n��rale, Sorbonne Paris Cit�� , Univ. Paris Diderot , Paris , France.
  2. Emmanuel Prothon: b D��partement de m��decine g��n��rale , Univ. Bordeaux , Bordeaux , France.
  3. Catherine Majerholc: a D��partement de m��decine g��n��rale, Sorbonne Paris Cit�� , Univ. Paris Diderot , Paris , France.
  4. Diana Barger: c ISPED, Centre INSERM U1219-Bordeaux Population Health , Univ. Bordeaux , Bordeaux , France.
  5. Yazdan Yazdanpanah: d Service de maladies infectieuses et tropicales (SMIT) , AP-HP, H��pital Bichat , Paris , France.
  6. Jean-Pierre Aubert: a D��partement de m��decine g��n��rale, Sorbonne Paris Cit�� , Univ. Paris Diderot , Paris , France.

Abstract

BACKGROUND: Many people in Europe remain undiagnosed for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV).
OBJECTIVES: To evaluate acceptability and effectiveness of a questionnaire designed to facilitate identification of risk factors for these viruses.
METHODS: We performed an observational study, in a prospectively enrolled cohort of patients in Paris (France) seen in 2014. Eighteen GPs administered a questionnaire to the first 50 patients, collecting information about risk factors. GPs were randomized into two groups: A (self-administered questionnaire) and B (GP-administered questionnaire). We used the overall response rate to assess the acceptability of the questionnaire. We used the rate of newly identified risk factors and compared the number of tests performed one year before and immediately after the intervention to assess the effectiveness of the questionnaire.
RESULTS: 842 patients were randomized: 349 (41.5%) in group A and 493 (58.5%) in group B. Acceptability was 88.5% (95%CI: 86.3-90.6); 93.1% (95%CI: 90.5-95.8) in-group A and 85.2% (95%CI: 82.1-88.3) in group B (P���=���0.0004). Prevalence of risk factors was 51.8% (95%CI: 48.2-54.4) and 58.3% were newly identified (95%CI: 52.9-63.7). The number of HIV tests performed during the four weeks after intervention increased by 27% compared to the same period one year before (P���=���0.22). It increased by 113% (P���=���0.005) and 135% (P���=���0.005) for HBV and HCV, respectively.
CONCLUSION: The questionnaire proved acceptable and effective in identifying risk factors for HIV, HBV and HCV in general practice.

Keywords

References

  1. Int J STD AIDS. 2010 Oct;21(10):669-78 [PMID: 21139144]
  2. Int J STD AIDS. 2014 Sep;25(10):695-704 [PMID: 24759563]
  3. Euro Surveill. 2016 Dec 1;21(48): [PMID: 27934585]
  4. BMC Infect Dis. 2013 May 02;13:200 [PMID: 23638870]
  5. Sante Publique. 2002 Jun;14(2):191-9 [PMID: 12375524]
  6. J Natl Med Assoc. 2006 Dec;98(12):1924-9 [PMID: 17225835]
  7. Sex Transm Infect. 2013 May;89(3):191-6 [PMID: 23044438]
  8. Patient Educ Couns. 2005 Apr;57(1):101-5 [PMID: 15797158]
  9. Swiss Med Wkly. 2011 Mar 08;141:w13178 [PMID: 21384286]
  10. Clin Infect Dis. 2012 Apr;54(8):1167-78 [PMID: 22291098]
  11. J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):446-53 [PMID: 16010168]
  12. Arch Intern Med. 2008 Jul 14;168(13):1458-64 [PMID: 18625927]
  13. PLoS One. 2011;6(9):e24736 [PMID: 21935447]

MeSH Term

Adolescent
Adult
Aged
Cohort Studies
Female
France
General Practice
HIV Infections
Hepatitis B
Hepatitis C
Humans
Male
Mass Screening
Middle Aged
Prevalence
Prospective Studies
Risk Factors
Surveys and Questionnaires
Young Adult

Word Cloud

Created with Highcharts 10.0.0questionnaireriskfactorsHIVB95%CI:hepatitisP���=���0virusHBVHCVacceptabilityeffectivenessperformedpatients5%grouppracticeidentificationobservationalstudyGPsusedrateassessnewlyidentifiedcomparednumbertestsoneyearintervention58increased005generalBACKGROUND:ManypeopleEuroperemainundiagnosedhumanimmunodeficiencyCOBJECTIVES:evaluatedesignedfacilitatevirusesMETHODS:prospectivelyenrolledcohortParisFranceseen2014Eighteenadministeredfirst50collectinginformationrandomizedtwogroups:self-administeredGP-administeredoverallresponseimmediatelyRESULTS:842randomized:34941493Acceptability88863-906931%905-958in-group852%821-8830004Prevalence518%482-5443%529-637fourweeks27%period22113%135%respectivelyCONCLUSION:provedacceptableeffectiveidentifyingC:Generalscreeningviral

Similar Articles

Cited By (1)